These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 44235)

  • 1. SK&F 92657, a novel antihypertensive acting by precapillary vasodilatation and beta-adrenoreceptor blockade.
    Taylor EM; Roe AM; Slater RA
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():433s-436s. PubMed ID: 44235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic profile of a new antihypertensive agent D,L-3-[2-(3-t-butylamino-2-hydroxypropoxy)phenyl]-6-hydrazinopyridazine (SK&F 92657).
    Taylor EM; Cameron D; Eden RJ; Fielden R; Owen DA
    J Cardiovasc Pharmacol; 1981; 3(2):337-54. PubMed ID: 6166805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the autonomic nervous system with SK&F 92657, a new antihypertensive agent causing direct arterial vasodilatation and beta-adrenoceptor blockade.
    Taylor EM; Eden RJ; Fielden R; Owen DA
    J Cardiovasc Pharmacol; 1981; 3(2):355-68. PubMed ID: 6166806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SK & F 95018, a vasodilator/beta-adrenoceptor antagonist.
    Swayne GT; Owen DA; Taylor EM; Eden RJ; Slater RA; Howson W
    Arch Int Pharmacodyn Ther; 1987 Oct; 289(2):251-66. PubMed ID: 2892473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of selective and non-selective beta-adrenoreceptor blockade on the haemodynamic effect of adrenaline during combined antihypertensive drug therapy.
    Houben H; Thien T; De Boo T; Lemmens W; Van Herwaarden CL; Fennis JF; Van 't Laar A
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():397s-399s. PubMed ID: 232027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Central cardiovascular effect of isoprenaline and some adrenergic beta blocking agents in neurogenic hypertensive dog: role of central beta-adrenoceptors (author's transl)].
    Montastruc P; Montastruc JL
    J Physiol (Paris); 1978; 74(7):651-8. PubMed ID: 218002
    [No Abstract]   [Full Text] [Related]  

  • 7. Activity of beta 2 adrenergic receptors in coronary arteries after cardioselective beta-blockade.
    Marchetti GV; Di Francesco GF; Baldoli E
    Basic Res Cardiol; 1981; 76(5):540-4. PubMed ID: 6118128
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacodynamic and pharmacokinetic studies on prizidilol and nipradilol (K-351), antihypertensive drugs with combined vasodilator and beta-adrenoceptor blocking actions, in rabbits.
    Kawashima K; Watanabe TX; Sokabe H
    Jpn J Pharmacol; 1984 Dec; 36(4):519-26. PubMed ID: 6151998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular actions of optical isomers of propranolol.
    Yamamoto J; Sekiya A; Maekawa H; Kato Y
    Jpn J Pharmacol; 1978 Aug; 28(4):627-31. PubMed ID: 32418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An assessment of beta-adrenoceptor blockade in man by prizidilol hydrochloride.
    Pitcher DW; Curry PV; Trounce JR
    Br J Clin Pharmacol; 1982 May; 13(5):711-6. PubMed ID: 6123343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative relationship between beta-adrenergic receptor number and physiologic responses as studied with a long-lasting beta-adrenergic antagonist.
    Terasaki WL; Linden J; Brooker G
    Proc Natl Acad Sci U S A; 1979 Dec; 76(12):6401-5. PubMed ID: 42915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the mechanism of the acute antihypertensive and vasodilator actions of several beta-adrenoceptor antagonists.
    Sybertz EJ; Baum T; Pula KK; Nelson S; Eynon E; Sabin C
    J Cardiovasc Pharmacol; 1982; 4(5):749-58. PubMed ID: 6182405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-adrenoreceptor blocking properties of new thienylethanolamine derivatives.
    Darias V; Madroñero R; del Río J
    Arzneimittelforschung; 1974 Nov; 24(11):1751-6. PubMed ID: 4155632
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-hypertension effect of vanylidilol: a phenylaldehyde alpha/beta-adrenoceptor blocker with endothelium-dependent and K+ channels opening-associated vasorelaxant activities.
    Chiu CC; Wu JR; Lee CH; Liou SF; Dai ZK; Chen IJ; Yeh JL
    Pharmacology; 2004 Mar; 70(3):140-51. PubMed ID: 14752234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of nadolol (SQ 11725), a beta-adrenergic antagonist lacking direct myocardial depression.
    Lee RJ; Evans DB; Baky SH; Laffan RJ
    Eur J Pharmacol; 1975; 33(2):371-82. PubMed ID: 241655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selectivity in new -adrenergic blocking agents. (3-Amino-2-hydroxypropoxy)benzamides.
    Shtacher G; Erez M; Cohen S
    J Med Chem; 1973 May; 16(5):516-9. PubMed ID: 4146253
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacological properties of dl-2-(3'-t-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl) thiazole hydrochloride (S-596), a new beta-adrenergic blocking agent (author's transl)].
    Hara Y; Sato E; Miyagishi A; Aono S; Nakatani H
    Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):707-20. PubMed ID: 94296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of cardiac and renal beta-receptors by low dose propranolol in normal subjects. Clues to its antihypertensive effect.
    Davies R; Pickering TG; Morganti A; Wilson M; Laragh JH
    Br Heart J; 1979 Mar; 41(3):331-5. PubMed ID: 34409
    [No Abstract]   [Full Text] [Related]  

  • 19. Vanidipinedilol: a vanilloid-based beta-adrenoceptor blocker displaying calcium entry blocking and vasorelaxant activities.
    Yeh JL; Liou SF; Liang JC; Huang YC; Chiang LC; Wu JR; Lin YT; Chen IJ
    J Cardiovasc Pharmacol; 2000 Jan; 35(1):51-63. PubMed ID: 10630733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of prizidilol hydrochloride (SK & F 92657), a new antihypertensive agent with beta-adrenoceptor antagonist and vasodilator activity with propranolol and hydralazine in normal volunteers.
    Steiner JA; Clancy A; Manghani KK; James IM
    Br J Clin Pharmacol; 1981 Oct; 12(4):573-8. PubMed ID: 6117309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.